Answers are grounded in this paper and cite their sources.
A new mitogenic factor has been isolated from tissue culture grade lactalbumin hydrolysate. Incubation of postconfluent Swiss 3T3 cells in serum-free medium containing lactalbumin hydrolysate resulted in enhanced synthesis and release of plasminogen activator. Sephadex G-100 gel filtration of concentrated, dialyzed lactalbumin hydrolysate revealed two fractions, LH-FI and LH-FII. LH-FI elutes at the void volume, indicative of high molecular weight, and contains all plasminogen activator stimulatory activity of the original lactalbumin hydrolysate, whereas LH-FII has no activity. In addition, LH-FI also induces DNA synthesis in Swiss 3T3 cells in a dose-dependent fashion, 1 to 2 microgram/ml being equivalent to 10% fetal calf serum. Again, LH-FII is without effect. Induction of DNA synthesis in LH-FI or serum-stimulated quiescent sparse cells followed essentially identical kinetics at least through the first 20 h. Furthermore, LH-FI also enhances 3T3 cell growth. Preliminary results of Sepharose 4B filtration of LH-FI reveal the presence of five subfractions each with plasminogen activator stimulatory as well as mitogenic activity.
No takes yet. Share an insight, caveat, or question.
Chou et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: